Dimension
Multi-stage VC with $850M backing companies at the intersection of life sciences and compute — drug discovery AI, lab infrastructure, and biotech software platforms.
Divergent Capital
Pre-seed fund led by Katie Shea and Lucy Wang, using an Atoms/Bits/Cells framework to back deep-tech founders modernizing essential systems.
Dorm Room Fund
Student-run pre-seed fund backing university/recent alumni founders
Double Point Ventures
Physician-led healthcare VC backing early- to growth-stage companies in therapeutics, diagnostics, medical devices, and digital health across the US.
Draper Associates
40+ years funding transformative companies with visionary founders
Duke Capital Partners
Duke University's official early-stage venture arm, funding Duke-connected founders in biotech, SaaS, B2B, and CPG via alumni capital and mentorship.
E14 Fund
MIT-affiliated pre-seed to Series A fund backing deep-tech founders from the MIT community, with first checks of $1M–$5M and a $50–100K fellowship program.
E2MC
US-based early-stage VC exclusively focused on the space economy, backing pre-seed and seed startups in SpaceTech, DeepTech, and adjacent dual-use technologies globally.
Easton Capital
Healthcare-focused fund taking a "classical," capital-efficient VC approach — 40% of its latest fund's founders are women, with five $1B+ exits.
Echo Health Ventures
Driving systemic health care transformation via strategic VC & growth equity
Eisai Innovation Inc.
Corporate venture arm of Eisai investing ~$5M per deal in neurology, oncology, diagnostics, and digital health globally. Founded 2019; targets early-stage biotech and digital health startups.
Elevage Medical Technologies
Austin-based growth-stage medtech investor backing FDA-regulated devices, diagnostics, lab tools, and healthcare IT companies through capital and operational support.
Skip the browsing. Get all 709 BioTech investors in one sheet — $39 one-time.
Filter by stage, sector and location in Excel or Google Sheets · Website, offices, stages, sectors, founded year, portfolio link, notes · CSV + Excel
Get the Complete BioTech Investor Database →Elm Street Ventures
Seed and early-stage fund backed by Yale investing in life sciences, clean tech, and deep science spinouts from Yale and Connecticut institutions.
Embark Ventures
Los Angeles-based pre-seed and seed fund focused on deep tech: robotics, bio-healthcare, materials science, semiconductors, and industrial automation.
Engine Ventures
Venture firm backing early-stage founders building transformative tech
Entrepreneurs First
Talent investor and pre-seed program turning exceptional individuals into funded founders across London, Paris, Bangalore, and San Francisco.
EOS BioInnovation
Investing in early-stage life science companies advancing novel therapeutics
Epic Ventures
Early-stage VC founded in 1994 in Salt Lake City, backing tech startups in SaaS, healthcare, cybersecurity, fintech, and future of work. Strong Mountain West focus; 288 investments and 60+ exits.
Evolution VC Partners
Solo investor (Gregg Smith) deploying personal capital across all stages into "Culture Tech" companies spanning consumer, fintech, health, AI, media, defense, and frontier tech. 250+ investments; no external fund.
F-Prime Capital
A leading global venture capital firm with over $5.3 billion under management, focused on backing entrepreneurs in breakthrough innovations that transform medicine and technology.
Fast Track Initiative (FTI)
Tokyo-headquartered life science VC founded in 2004, investing in early-stage biotechnology, therapeutics, and healthcare startups with a Japan-anchored global network.
FCA Venture Partners
Nashville-based healthcare VC founded in 1996, backing Seed through Series B companies in health tech, providers, payers, pharma, and innovative care delivery. $2–8M checks; $335M+ capital raised across five funds.
Felicis
Early-stage VC backing founders reinventing massive markets across sectors
FemHealth Ventures
Early-stage VC firm targeting women's health across drugs, devices, diagnostics, and digital health using a proprietary three-category framework.
Showing 121–144 of 436 investors
This list has 436 investors. The full database has 709.
Get all 709 BioTech investors in one sheet for $39 one-time. Filter by stage, sector and location in Excel or Google Sheets · Website, offices, stages, sectors, founded year, portfolio link, notes · CSV + Excel
Get the Complete BioTech Investor Database →